First Room-Temperature Drug for MS Approved - Multiple sclerosis - Brief Article

Author: Elaine Kierl Gangel
Date: March 15, 2002

The U.S. Food and Drug Administration has approved interferon beta-1b (Betaseron), the first and only room-temperature therapy to treat relapsing-remitting multiple sclerosis. It will be available mid-2002.

This therapy option will allow patients to continue treatment uninterrupted and provide greater convenience to them. Common side effects of interferon beta-1b include influenza-like symptoms, shortness of breath, and injection site reactions.

COPYRIGHT 2002 American Academy of Family PhysiciansCOPYRIGHT 2002 Gale Group

© 2006,, All Rights Reserved.